Phibro Animal Health Corporation (PAHC) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Win.
44/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 10 wins, 2 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
LosePAHC / S&P -42.99% / 15.20% |
WinPAHC / S&P 17.12% / 15.00% |
WinPAHC / S&P 105.04% / 50.40% |
| 2026-Q13/3 |
WinPAHC / S&P 48.39% / -4.33% |
WinPAHC / S&P 25.98% / 11.30% |
WinPAHC / S&P 200.00% / 27.70% |
| 2025-Q42/3 |
LosePAHC / S&P -7.41% / 2.65% |
WinPAHC / S&P 32.39% / 9.00% |
WinPAHC / S&P 370.83% / 13.40% |
| 2025-Q33/3 |
WinPAHC / S&P 58.94% / 8.12% |
WinPAHC / S&P 33.71% / 4.61% |
WinPAHC / S&P 288.37% / 13.45% |
| 2025-Q23/3 |
WinPAHC / S&P 20.16% / 10.94% |
WinPAHC / S&P 27.37% / 4.83% |
WinPAHC / S&P 1883.33% / 10.63% |
| 2025-Q13/3 |
WinPAHC / S&P 2.22% / -4.27% |
WinPAHC / S&P 19.12% / 4.98% |
WinPAHC / S&P 136.36% / 10.57% |
| 2024-Q42/3 |
LosePAHC / S&P -6.28% / 2.41% |
WinPAHC / S&P 12.63% / 5.25% |
WinPAHC / S&P 29.73% / 6.15% |
| 2024-Q32/3 |
WinPAHC / S&P 35.10% / 5.89% |
WinPAHC / S&P 7.17% / 5.89% |
LosePAHC / S&P -17.31% / 6.11% |
| 2024-Q21/3 |
WinPAHC / S&P 30.61% / 4.28% |
LosePAHC / S&P 4.07% / 5.38% |
LosePAHC / S&P -92.68% / 5.12% |
| 2024-Q11/3 |
WinPAHC / S&P 12.65% / 10.56% |
LosePAHC / S&P 2.19% / 5.71% |
LosePAHC / S&P -53.52% / 5.59% |
| 2023-Q40/3 |
LosePAHC / S&P -8.25% / 11.69% |
LosePAHC / S&P 1.02% / 6.81% |
LosePAHC / S&P -58.89% / 7.78% |
| 2023-Q30/3 |
LosePAHC / S&P -6.01% / -3.27% |
LosePAHC / S&P 1.73% / 7.52% |
LosePAHC / S&P -54.78% / -5.03% |
| 2023-Q20/3 |
LosePAHC / S&P -9.76% / 8.74% |
LosePAHC / S&P 3.78% / 9.50% |
LosePAHC / S&P -32.23% / -8.57% |
| 2023-Q11/3 |
WinPAHC / S&P 15.11% / 7.50% |
LosePAHC / S&P 7.81% / 10.77% |
LosePAHC / S&P -51.03% / -15.69% |
| 2022-Q40/3 |
LosePAHC / S&P 1.91% / 7.56% |
LosePAHC / S&P 10.54% / 11.88% |
LosePAHC / S&P -31.30% / -17.99% |
| 2022-Q30/3 |
LosePAHC / S&P -29.95% / -4.88% |
LosePAHC / S&P 12.58% / 13.47% |
LosePAHC / S&P -4.17% / -1.41% |
| 2022-Q21/3 |
WinPAHC / S&P -3.52% / -16.10% |
LosePAHC / S&P 13.07% / 13.71% |
LosePAHC / S&P -9.70% / 11.04% |
| 2022-Q11/3 |
WinPAHC / S&P -1.75% / -4.60% |
LosePAHC / S&P 13.56% / 15.97% |
LosePAHC / S&P 36.79% / 42.23% |
| 2021-Q40/3 |
LosePAHC / S&P -4.68% / 11.03% |
LosePAHC / S&P 10.20% / 15.00% |
LosePAHC / S&P 20.18% / 96.40% |
| 2021-Q30/3 |
LosePAHC / S&P -25.04% / 0.58% |
LosePAHC / S&P 5.83% / 10.77% |
LosePAHC / S&P 13.21% / 69.42% |
| 2021-Q22/3 |
WinPAHC / S&P 18.87% / 8.55% |
LosePAHC / S&P 4.12% / 6.58% |
WinPAHC / S&P 63.41% / 51.81% |
| 2021-Q12/3 |
WinPAHC / S&P 26.31% / 6.17% |
LosePAHC / S&P -2.37% / -1.06% |
WinPAHC / S&P 17.78% / 7.39% |
| 2020-Q43/3 |
WinPAHC / S&P 12.33% / 12.15% |
WinPAHC / S&P -1.89% / -3.72% |
WinPAHC / S&P 15.96% / -33.42% |
| 2020-Q32/3 |
LosePAHC / S&P -33.39% / 8.93% |
WinPAHC / S&P -1.44% / -2.04% |
WinPAHC / S&P 4.95% / -27.10% |
| 2020-Q20/3 |
LosePAHC / S&P 9.20% / 20.54% |
LosePAHC / S&P -3.34% / -0.46% |
LosePAHC / S&P -39.26% / -27.11% |
| 2020-Q11/3 |
WinPAHC / S&P -2.19% / -19.60% |
LosePAHC / S&P -2.10% / 3.47% |
LosePAHC / S&P -46.43% / -14.75% |
| 2019-Q41/3 |
WinPAHC / S&P 16.99% / 9.07% |
LosePAHC / S&P -3.07% / 5.36% |
LosePAHC / S&P -47.78% / 2.99% |
| 2019-Q30/3 |
LosePAHC / S&P -32.47% / 1.70% |
LosePAHC / S&P -1.11% / 5.02% |
LosePAHC / S&P -37.27% / 0.21% |
| 2019-Q20/3 |
LosePAHC / S&P -3.34% / 4.30% |
LosePAHC / S&P 0.98% / 6.64% |
LosePAHC / S&P -15.63% / 8.65% |
| 2019-Q11/3 |
LosePAHC / S&P 3.04% / 13.65% |
LosePAHC / S&P 4.09% / 8.12% |
WinPAHC / S&P 17.48% / 14.29% |
| 2018-Q40/3 |
LosePAHC / S&P -24.76% / -13.52% |
LosePAHC / S&P 7.03% / 9.05% |
LosePAHC / S&P 17.65% / 18.23% |
| 2018-Q30/3 |
LosePAHC / S&P -6.64% / 7.71% |
LosePAHC / S&P 7.41% / 10.21% |
LosePAHC / S&P -5.29% / 19.06% |
| 2018-Q21/3 |
WinPAHC / S&P 16.24% / 3.43% |
LosePAHC / S&P 7.29% / 9.03% |
LosePAHC / S&P -1.23% / 14.46% |
| 2018-Q11/3 |
WinPAHC / S&P 18.80% / -0.76% |
LosePAHC / S&P 5.85% / 7.68% |
LosePAHC / S&P -11.73% / 12.46% |
| 2017-Q40/3 |
LosePAHC / S&P -9.30% / 6.64% |
LosePAHC / S&P 4.22% / 7.03% |
LosePAHC / S&P 2.68% / 13.82% |
| 2017-Q30/3 |
LosePAHC / S&P 0.28% / 4.48% |
LosePAHC / S&P 2.30% / 5.68% |
LosePAHC / S&P -10.53% / 17.57% |
| 2017-Q21/3 |
WinPAHC / S&P 32.23% / 3.09% |
LosePAHC / S&P 1.70% / 4.83% |
LosePAHC / S&P -21.36% / 17.74% |
| 2017-Q10/3 |
LosePAHC / S&P -3.76% / 6.07% |
LosePAHC / S&P 1.51% / 3.67% |
LosePAHC / S&P -16.49% / 13.32% |
| 2016-Q41/3 |
WinPAHC / S&P 8.19% / 3.82% |
LosePAHC / S&P 0.12% / 2.09% |
LosePAHC / S&P -21.58% / 7.05% |
| 2016-Q33/3 |
WinPAHC / S&P 46.23% / 3.85% |
WinPAHC / S&P 0.55% / 0.20% |
WinPAHC / S&P 25.83% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | PAHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -0.71% | 20.78% |
| Annualized return | -0.71% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | PAHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 69.05% | 83.14% |
| Annualized return | 11.07% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | PAHC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 74.67% | 319.30% |
| Annualized return | 5.74% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.